IMAX executive Lister gifts 2,000 shares to charity fund

IMAX Corporation executive Robert D. Lister, the Chief Legal Officer and Senior Executive Vice President, reported a charitable transfer of company stock.

Rhea-AI Filing Summary

IMAX Corporation executive Robert D. Lister, the Chief Legal Officer and Senior Executive Vice President, reported a charitable transfer of company stock. On December 11, 2025, he gifted 2,000 common shares of IMAX Corporation to a donor-advised fund, with the shares to be used for charitable purposes. The Form 4 shows the transaction at a price of $0.00, reflecting that this was a gift rather than a sale.

Following this transaction, Mr. Lister beneficially owns 159,421 common shares and holds 70,609 restricted share units. The filing notes that the timing of the gift relates to changes in tax regulations affecting charitable donations that take effect on January 1, 2026.

Insider Trade Summary

2,000 shares gifted

Gift 2 txns

Insider LISTER ROBERT D

Role Chief Legal Officer Sr Exec VP

Type	Security	Shares	Price	Value
Gift	common shares	2,000	$0.00	$0.00
holding	common shares (opening balance)	--	--	--

Holdings After Transaction: common shares — 159,421 shares (Direct); common shares (opening balance) — 161,421 shares (Direct)

Footnotes (2)

1. F1. On December 11, 2025, Mr. Lister gifted 2,000 common shares of IMAX Corporation to a donor-advised fund, which will use the gifted shares for charitable purposes. The timing of this transfer relates to changes in tax regulations to charitable donations that takes effect on January 1, 2026.
2. F2. Mr. Lister's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 159,421, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IMAX (IMAX) report for Robert D. Lister?

The filing reports that Robert D. Lister, IMAX Corporation's Chief Legal Officer and Senior Executive Vice President, gifted 2,000 common shares of IMAX Corporation stock to a donor-advised fund on December 11, 2025.

Was the IMAX (IMAX) insider transaction a sale or a gift?

The transaction was a gift. The Form 4 lists the disposition of 2,000 common shares with a transaction price of $0.00, indicating no sale proceeds were received.

How many IMAX (IMAX) shares does Robert D. Lister own after the reported transaction?

After the gift, Robert D. Lister beneficially owns 159,421 common shares of IMAX Corporation and has 70,609 restricted share units outstanding.

What was the purpose of the gifted IMAX (IMAX) shares?

The 2,000 gifted common shares were transferred to a donor-advised fund, which will use the shares for charitable purposes, according to the explanation provided.

Why was the timing of Robert D. Lister's IMAX (IMAX) share gift significant?

The filing states that the timing of the December 11, 2025 transfer relates to changes in tax regulations to charitable donations that take effect on January 1, 2026.

What is Robert D. Lister's role at IMAX (IMAX)?

Robert D. Lister is identified in the filing as an officer of IMAX Corporation, serving as Chief Legal Officer and Senior Executive Vice President.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LISTER ROBERT D

(Last) (First) (Middle)

902 BROADWAY

20TH FLOOR

(Street)

NEW YORK NY 10010-6002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer Sr Exec VP

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								161,421	D
common shares	12/11/2025		G		2,000(1)	D	$0.00	159,421(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On December 11, 2025, Mr. Lister gifted 2,000 common shares of IMAX Corporation to a donor-advised fund, which will use the gifted shares for charitable purposes. The timing of this transfer relates to changes in tax regulations to charitable donations that takes effect on January 1, 2026.

2. Mr. Lister's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 159,421, respectively.

Remarks:

	/s/ Kenneth I. Weissman (attorney-in-fact for Robert D. Lister)	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.